Goldman Sachs’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-265
| Closed | -$2.35K | – | 5189 |
|
|
2024
Q4 | $2.35K | Buy |
+265
| New | +$2.35K | ﹤0.01% | 4982 |
|
|
2023
Q2 | – | Sell |
-89
| Closed | -$24.3K | – | 5057 |
|
|
2023
Q1 | $24.3K | Sell |
89
-15
| -14% | -$4.1K | ﹤0.01% | 4861 |
|
|
2022
Q4 | $30.7K | Sell |
104
-37
| -26% | -$10.9K | ﹤0.01% | 4847 |
|
|
2022
Q3 | $50K | Sell |
141
-64
| -31% | -$22.7K | ﹤0.01% | 5036 |
|
|
2022
Q2 | $90K | Sell |
205
-45
| -18% | -$19.8K | ﹤0.01% | 5147 |
|
|
2022
Q1 | $189K | Sell |
250
-137
| -35% | -$104K | ﹤0.01% | 5121 |
|
|
2021
Q4 | $483K | Buy |
387
+56
| +17% | +$69.9K | ﹤0.01% | 4548 |
|
|
2021
Q3 | $669K | Buy |
331
+224
| +209% | +$453K | ﹤0.01% | 4224 |
|
|
2021
Q2 | $266K | Sell |
107
-448
| -81% | -$1.11M | ﹤0.01% | 4766 |
|
|
2021
Q1 | $1.38M | Buy |
555
+291
| +110% | +$725K | ﹤0.01% | 3687 |
|
|
2020
Q4 | $748K | Sell |
264
-138
| -34% | -$391K | ﹤0.01% | 3618 |
|
|
2020
Q3 | $949K | Buy |
402
+238
| +145% | +$562K | ﹤0.01% | 3342 |
|
|
2020
Q2 | $390K | Buy |
164
+150
| +1,071% | +$357K | ﹤0.01% | 3709 |
|
|
2020
Q1 | $28K | Buy |
+14
| New | +$28K | ﹤0.01% | 4324 |
|
|
2018
Q3 | – | Sell |
-73
| Closed | -$378K | – | 4196 |
|
|
2018
Q2 | $378K | Sell |
73
-39
| -35% | -$202K | ﹤0.01% | 3639 |
|
|
2018
Q1 | $918K | Buy |
112
+97
| +647% | +$795K | ﹤0.01% | 3233 |
|
|
2017
Q4 | $131K | Buy |
+15
| New | +$131K | ﹤0.01% | 3925 |
|